Thursday 14 April 2016

Taiwan Pharmaceutical Market Analysis And Forecast Report



"The Report The Pharmaceutical Market: Taiwan provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"

OVERVIEW OF THE PHARMACEUTICAL MARKET IN TAIWAN

We continue to view Taiwan as a challenging market for multinationals, mostly on account of the difficult pricing and reimbursement environment, which is due to undergo further changes. Specifically, as part of the Second Generation National Health Insurance (NHI) programme, which becomes effective in 2013, a new reimbursement system is expected to be rolled out in Taiwan. The American Chamber of Commerce in Taipei (AmCham), in its latest White Paper published in 2012, wrote that it hoped that the new system - known as the Drug Reimbursement Item and Payment Scheme (DRIPS) - will not become so complicated as to cause delays in patient access to innovative new drugs.


Headline Expenditure Projections

  • Pharmaceuticals: TWD135.10bn (US$4.59bn) in 2011 to TWD140.44bn (US$4.71bn) in 2012; +4.2% in local currency terms and +2.6% in US dollar terms. US dollar forecastback in the positive territory, unlike inQ412, on account of exchange rate fluctuations.
  • Healthcare: TWD953.29bn (US$32.42bn) in 2011 to TWD1,018bn (US$34.15bn) in 2012; +6.5% in local currency terms and +5.3% in US dollar terms. Local currency forecastslightly up sinceQ412, on account of macroeconomic factors.
  • Medical devices: TWD52.63bn (US$1.79bn) in 2011 to TWD55.09bn (US$1.85bn) in 2012; +4.7% in local currency terms and +4.3% in US dollar terms. Local currency forecastslightly up sinceQ412, on account of macroeconomic factors.

Competitive Landscape

The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

Download Sample copy of this Report at:

Table of Contents

BMI Industry View7
SWOT10
Political12
Economic13
Business Environment14
Industry Forecast15

Pharmaceutical Market Forecast15

Table: Pharmaceutical Sales, Historical Data And Forecasts (Taiwan 2010-2018)17

Healthcare Market Forecast18

Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2010-2018)20
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2010-2018)21
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Taiwan 2010-2018)21

Presciption Drug Market Forecast21

Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Taiwan 2010-2018)23

Patented Drug Market Forecast24

Table: Top 10 Pharmaceuticals In Taiwan According To BNHI Expenditure During 200825
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Taiwan 2010-2018)26

Generic Drug Forecast26

Table: Generics Drug Market Indicators, Historical Data And Forecasts (Taiwan 2010-2018)29

OTC Medicine Market Forecast29

Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Taiwan 2010-2018)32

Browse Our Press Releases by Prnewswire:


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact

Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
USA: Canada Toll Free: 866-997-4948
Tel: +1-518-621-2074

No comments:

Post a Comment